Cargando…

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review

Background and Objectives: So far, there is little evidence of the ambient effect on motor and non-motor symptoms of Parkinson’s Disease (PD). This systematic review aimed to determine the association between ambiental factors and the progression of PD. Materials and Methods: A systematic literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bougea, Anastasia, Papagiannakis, Nikolas, Simitsi, Athina-Maria, Panagiotounakou, Elpida, Chrysovitsanou, Chrysa, Angelopoulou, Efthalia, Koros, Christos, Stefanis, Leonidas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962232/ https://www.ncbi.nlm.nih.gov/pubmed/36837495 http://dx.doi.org/10.3390/medicina59020294

Ejemplares similares

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review
por: Koros, Christos, et al.
Publicado: (2023)

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report
por: Koros, Christos, et al.
Publicado: (2023)

Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It?
por: Kapsomenakis, Alexandros, et al.
Publicado: (2023)

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
por: Ravanidis, Stylianos, et al.
Publicado: (2020)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Prosopagnosia, Other Specific Cognitive Deficits, and Behavioral Symptoms: Comparison between Right Temporal and Behavioral Variant of Frontotemporal Dementia
por: Koros, Christos, et al.
Publicado: (2022)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease
por: Ravanidis, Stylianos, et al.
Publicado: (2021)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)

Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
por: Petropoulou-Vathi, Lilian, et al.
Publicado: (2022)

APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
por: Papastefanopoulou, Vasiliki, et al.
Publicado: (2022)

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature
por: Vakadaris, Georgios, et al.
Publicado: (2023)

Factors associated with perceived social support of patients with multiple sclerosis
por: Papa, Aikaterini, et al.
Publicado: (2021)

Honey’s Antioxidant and Antimicrobial Properties: A Bibliometric Study
por: Stefanis, Christos, et al.
Publicado: (2023)

Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
por: Elkouris, Maximilianos, et al.
Publicado: (2019)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Lipid level alteration in human and cellular models of alpha synuclein mutations
por: Avisar, Hila, et al.
Publicado: (2022)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

COVID-19 on the spectrum: a scoping review of hygienic standards
por: Voidarou, Chrysa, et al.
Publicado: (2023)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
por: Bougea, Anastasia
Publicado: (2023)

Shoulder Dysfunction in Parkinson Disease: Review of Clinical, Imaging Findings and Contributing Factors
por: Paggou, Dimitra, et al.
Publicado: (2023)

Organochlorine pesticide levels in Greek patients with Parkinson’s disease
por: Dardiotis, Efthimios, et al.
Publicado: (2020)

Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2022)

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center
por: Skarlis, Charalampos, et al.
Publicado: (2022)

MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review
por: Bougea, Anastasia
Publicado: (2022)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

B12 as a Treatment for Peripheral Neuropathic Pain: A Systematic Review
por: Julian, Thomas, et al.
Publicado: (2020)

Mobile App Interventions for Parkinson’s Disease, Multiple Sclerosis and Stroke: A Systematic Literature Review
por: Triantafyllidis, Andreas, et al.
Publicado: (2023)

Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Clock-Drawing Tasks as Predictive Measurements for Disease Classification Among Patients With Parkinson’s Disease and Essential Tremor
por: Bougea, Anastasia M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38sgp0k8o57onvn67prb5m42tf